Scholarly Index
Karen H. Lu
The University of Texas MD Anderson Cancer Center; 34,176 total citations; 687 total publications; best world rank #36
The University of Texas MD Anderson Cancer Center
34,176Total citations
687Total publications
89H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 36 | US 17 | 99.68 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 55 | US 30 | 99.56 |
| Genetic factors in colorectal cancer | Lifetime | 112 | US 61 | 99.41 |
| BRCA gene mutations in cancer | Lifetime | 101 | US 53 | 99.08 |
| Multiple and Secondary Primary Cancers | Lifetime | 81 | US 36 | 98.88 |
| Cancer Genomics and Diagnostics | Lifetime | 574 | US 321 | 98.92 |
| Cancer-related molecular mechanisms research | Lifetime | 727 | US 187 | 97.99 |
| Colorectal Cancer Screening and Detection | Lifetime | 784 | US 348 | 97.32 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 424 | US 246 | 96.79 |
| Cancer Risks and Factors | Lifetime | 634 | US 332 | 95.89 |
| PARP inhibition in cancer therapy | Lifetime | 628 | US 283 | 93.42 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 148 | US 44 | 97.55 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 824 | US 174 | 88.92 |
| PARP inhibition in cancer therapy | 2021-2025 | 583 | US 222 | 84.92 |
| BRCA gene mutations in cancer | 2021-2025 | 931 | US 400 | 81.51 |